Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Authors
Keywords
Schistosomiasis, Drug repurposing, Drug screening, Protein kinase inhibitor
Journal
Parasites & Vectors
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-08-12
DOI
10.1186/s13071-015-1023-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activities ofN,N′-Diarylurea MMV665852 Analogs against Schistosoma mansoni
- (2015) Noemi Cowan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis
- (2015) Erinna F Lee et al. Future Medicinal Chemistry
- Re-positioning protein-kinase inhibitors against schistosomiasis
- (2015) Verena Gelmedin et al. Future Medicinal Chemistry
- Orally Active Antischistosomal Early Leads Identified from the Open Access Malaria Box
- (2014) Katrin Ingram-Sieber et al. PLoS Neglected Tropical Diseases
- Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib
- (2014) Svenja Beckmann et al. International Journal for Parasitology-Drugs and Drug Resistance
- Repurposing drugs for the treatment and control of helminth infections
- (2014) Gordana Panic et al. International Journal for Parasitology-Drugs and Drug Resistance
- Diagnosis and treatment of schistosomiasis in children in the era of intensified control
- (2013) Stefanie Knopp et al. Expert Review of Anti-Infective Therapy
- Imatinib activity on Schistosoma mansoni
- (2013) Naftale Katz et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment
- (2013) Belen Pedrique et al. Lancet Global Health
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition
- (2011) A. G. Gilmartin et al. CLINICAL CANCER RESEARCH
- Imatinib has a fatal impact on morphology, pairing stability and survival of adult Schistosoma mansoni in vitro
- (2010) S. Beckmann et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective?
- (2010) Colette Dissous et al. TRENDS IN PARASITOLOGY
- The genome of the blood fluke Schistosoma mansoni
- (2009) Matthew Berriman et al. NATURE
- Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni
- (2009) T. MANNECK et al. PARASITOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation